Core Scientific (CORZ) Cost of Revenue (2021 - 2026)

Core Scientific (CORZ) has 6 years of Cost of Revenue data on file, last reported at $85.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 19.39% year-over-year to $85.1 million; the trailing twelve-month figure through Mar 2026 stood at $294.9 million (down 17.9% YoY), and the FY2025 full-year result was $281.1 million, down 27.84% from the prior year.
• Cost of Revenue rose to $85.1 million in Q1 2026, from $59.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $189.6 million in Q3 2022 to a low of $59.0 million in Q4 2025.
• A 5-year average of $103.9 million and a median of $95.5 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue surged 246.61% in 2022 and plunged 48.6% in 2023, its largest moves.
• Tracing CORZ's Cost of Revenue over 5 years: stood at $168.5 million in 2022, then slumped by 39.09% to $102.6 million in 2023, then retreated by 12.15% to $90.2 million in 2024, then plunged by 34.55% to $59.0 million in 2025, then jumped by 44.28% to $85.1 million in 2026.
• Business Quant data shows CORZ's Cost of Revenue at $85.1 million in Q1 2026, $59.0 million in Q4 2025, and $77.2 million in Q3 2025.